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Abstract
Background: The initial acquisition and early development of the intestinal microbiome during infancy are
important to human health across the lifespan. Mode of birth, antibiotic administration, environment of care,
and nutrition have all been shown to play a role in the assembly of the intestinal microbiome during early
life. For preterm infants, who are disproportionately at risk of inflammatory intestinal disease (i.e., necrotizing
enterocolitis), a unique set of clinical factors influence the establishment of the microbiome. The purpose of
this study was to establish the influence of nutritional exposures on the intestinal microbiome in a cohort of
preterm infants early in life.
Results: Principal component analysis of 199 samples from 30 preterm infants (<32 weeks) over the first
60 days following birth showed that the intestinal microbiome was influenced by postnatal time (p < 0.001,
R2 = 0.13), birth weight (p < 0.001, R2 = 0.08), and nutrition (p < 0.001, R2 = 0.21). Infants who were fed breast
milk had a greater initial bacterial diversity and a more gradual acquisition of diversity compared to infants
who were fed infant formula. The microbiome of infants fed breast milk were more similar regardless of birth
weight (p = 0.049), in contrast to the microbiome of infants fed infant formula, which clustered differently
based on birth weight (p < 0.001). By adjusting for differences in gut maturity, an ordered succession of
microbial phylotypes was observed in breast milk-fed infants, which appeared to be disrupted in those fed
infant formula. Supplementation with pasteurized donor human milk was partially successful in promoting a
microbiome more similar to breast milk-fed infants and moderating rapid increases in bacterial diversity.
Conclusions: The preterm infant intestinal microbiome is influenced by postnatal time, birth weight,
gestational age, and nutrition. Feeding with breast milk appears to mask the influence of birth weight,
suggesting a protective effect against gut immaturity in the preterm infant. These findings suggest not only a
microbial mechanism underpinning the body of evidence showing that breast milk promotes intestinal health
in the preterm infant but also a dynamic interplay of host and dietary factors that facilitate the colonization
of and enrichment for specific microbes during establishment of the preterm infant microbiota.
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Background
The initial acquisition and early development of the in-
testinal microbiome during infancy are important to hu-
man health across the lifespan [1–3]. Several factors
influence the assembly of the intestinal microbiome dur-
ing infancy. Mode of birth [4], antibiotic administration
[5], environment of care [6], and nutritional exposures,
and most notably breastfeeding [7] have all been shown
to play an important role in acquisition of the intestinal
microbiome. Exposure to breast milk during infancy ap-
pears to be particularly important in shaping the micro-
biome [8]. Among preterm infants, gestational age at
birth and postnatal age at observation have also been
shown to be relevant to the characteristics of their
microbiome [9]. We know from clinical studies that ex-
clusively breastfed full-term infants harbor specific
health-promoting bacteria (“pioneer” bacteria) that are
associated with improved immune status [8, 10]. We
also know that the microbiota of breast- vs. formula-fed
infants have a more profound effect on neonatal entero-
cyte genes that influence host protection and develop-
ment [10]. What is not known is the impact of ingested
expressed breast milk from mothers delivering prema-
turely on the composition of the preterm infant’s intes-
tinal microbiome.
Children who are born preterm suffer a myriad of
complications as a result of immature organs that are
ill suited for the extrauterine environment at the time
of their birth. Of the preterm infant patient popula-
tion, those born prior to 32 weeks are especially vul-
nerable. These children require the majority of health
care resources available because they are at the high-
est risk of neonatal morbidities, many of which have
a lasting influence on health throughout childhood
and across the lifespan [11, 12].
Preterm infants born prior to 32 weeks of gestation
are disproportionately at risk for excessive intestinal in-
flammatory conditions, particularly necrotizing entero-
colitis (NEC). NEC affects approximately 10% of
preterm infants born less than 1500 g and is a major
contributor to neonatal morbidity and mortality [13].
Preterm infants are also commonly at risk for intestinal
dysbiosis that is associated with birth by cesarean sec-
tion, maternal infection (e.g., chorioamnionitis), routine
administration of antibiotics during the perinatal period,
and a decreased exposure to maternal breast milk. In
sum, intestinal dysbiosis in a preterm infant is problem-
atic for both short- and long-term health and is thought
to be a major risk factor for NEC [14].
Human breast milk is strongly recommended by the
Committee on Nutrition of the European Society of
Paediatric Gastroenterology, Hepatology and Nutrition
as the best source of nutrition for newborn infants,
including preterm infants [15]. Breast milk contains
important developmental and immune-promoting fac-
tors (oligosaccharides, immunoglobulins, etc.) that are
thought to protect the newborn both passively and
actively against excessive intestinal inflammation [16].
Specifically, the ingestion of maternal breast milk
(MBM) from mothers delivering prematurely, particu-
larly when given as soon as possible after birth, is
considered a preventative measure for the develop-
ment of NEC [17, 18]. In the absence of expressed
MBM, pasteurized donor human milk (PDHM) or a
specialized preterm infant formula (IF) is used as the
enteric source of nutrition in this population. How-
ever, neither of these latter nutritional approaches is
as effective as MBM in establishing optimal immune
health or in the prevention of NEC [19].
Recognizing that breast milk influences initial bacterial
colonization and that MBM given to preterm infants can
prevent NEC, we analyzed the influence of different
forms of infant nutrition on the initial colonization
process in 30 preterm infants. Few longitudinal studies
evaluating the influence of nutrition on the preterm in-
fant’s intestinal microbiome have been conducted, and
to our knowledge, no study has evaluated the influence
of PDHM on the early acquisition of the intestinal
microbiome and how this differs from MBM and infant
formula. Thus, the purpose of this study was to deter-
mine the composition of the intestinal microbiome of 30
preterm infants born <32 weeks of gestation for a period
of approximately 6 weeks after birth who had been ex-
posed to different nutritional regimens.
Results
Diet, maturity, and postnatal age are the greatest drivers
of preterm infant microbiome composition
This study included three groups of 10 preterm infants
born prior to 32 weeks of gestation (n = 30). The infants
were grouped based on a predominant diet of MBM,
PDHM, or IF. Stool samples were collected daily while
the infant was hospitalized, and weekly samples were an-
alyzed for microbiome compositional differences using
16S rDNA-based sequencing.
As shown in Fig. 1, 40% of the variance in microbiome
composition is explained by the first three principal
components (Bray-Curtis PCA, which best explained the
variance in the data among the metrics tested; see
“Methods” section). In Fig. 1a, the clustering in micro-
biome samples based on diet are shown, where the ma-
jority of the MBM samples cluster separately from the IF
samples. Figure 1b shows that the birth weight of the in-
fant at the time of birth also contributes to the cluster-
ing of the microbiome, with infants born less than
1000 g (ELBW) grouped separately from infants born
greater than 1000 g (VLBW). MBM samples cluster to-
gether regardless of birth weight, whereas IF samples
Gregory et al. Microbiome  (2016) 4:68 Page 2 of 15
Fig. 1 (See legend on next page.)
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formed two clusters by birth weight and gestational age.
Figure 1c illustrates that postnatal week of life also ap-
pears to have a dominant role in determining micro-
biome composition that is largely independent of diet, as
most samples after the first 3 weeks of life (“late”) clus-
tered together along PC1 (18% of variance) separate
from all of the samples within this period (“early”). This
clustering is further supported based on unweighted
UniFrac-based analyses of microbiome composition
(Fig. 2).
Distinct trajectories of bacterial diversity by diet
Following the initial PCA analyses that highlighted the
importance of the infant’s age following birth (i.e., week
of life) with regard to diet in our analyses, we sought to
identify the differences in diversity (as assessed using
Shannon indices; listed in Additional file 1: Table S2)
over time in the microbiome between the different in-
fant feeding groups. To account for the non-
independence of the samples given that multiple samples
were collected from the same infant over time, we used
a linear mixed-effects modeling approach (similar to
[20]) in order to control for the non-independence of
the samples and account for different trajectories based
on gestational age of the infants. All three nutrition
groups exhibit a significant increase in bacterial diver-
sity over postnatal time (Fig. 3a and Additional file 1:
Table S3), though the groups are especially distinct
with regard to the trajectories with which they in-
crease in diversity from birth over the 60-day period.
(See figure on previous page.)
Fig. 1 Infant microbiota composition in preterm gut driven by diet and birth weight. Principal component analysis (PCA) of 199 samples from
the 30 infants over the first 60 days based on Bray-Curtis distances between samples [2000 reads/sample]. Scatterplots are colored based on the
following: a nutritional exposures on a sample-by-sample basis [MBM maternal breast milk, DM pasteurized human donor milk, IF infant formula,
NPO nil per os, nothing by mouth]; b birth weight class [VLBW very low birth weight infants 1000–1500 g, ELBW extremely low birth weight infants
<1000 g]; and c week of life [shades of yellow—“early” samples <3 weeks; shades of blue—“late” samples after 3 weeks]. Early samples cluster
together regardless of nutritional exposures. Closer proximity of samples (points) equals more similar microbiota composition. Separation
of samples within each category is significant [FDR-adjusted PERMANOVA p < 0.001], and R2 values are noted
Fig. 2 Unweighted UniFrac-based analyses of microbiomes. Clustering of samples using phylogeny-based, unweighted (“presence-absence”)
UniFrac metric of microbiome composition [6965 reads/sample; ellipses for each point represent 95% confidence intervals based on jackknifed (1000×)
values]. Samples are colored based on a study group, b birth weight class, and c nutritional exposures. Only samples with >3 weeks postnatal age are
plotted [123 samples]. Separation of samples within each category is significant [FDR-adjusted PERMANOVA p < 0.001], and R2 values are noted
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Bacterial diversity levels started more simply but
rapidly increased to higher ultimate diversity levels in
IF- and PDHM-fed samples compared to matched
MBM-fed infant samples that exhibited a more mea-
sured initial increase in diversity. Further, variance
and confidence intervals for the models of PDHM-
and IF-fed infants were notably high. Adjusting for
gestational age better accounted for the differences in
trajectories for all nutritional groups (Fig. 3b), that is,
there was a 13–579% reduction in overall variance
with almost no variance (0.0001) observed in random
effects models for MBM infants diversity trajectories,
as well as both strong correlations to the model fit
lines and much lower confidence intervals for both
PDHM- and IF-fed infants (Fig. 3c). This suggests
again that gestational age (or gut maturity) had as
much influence on the diversity of the microbiome as
any dietary regimen.
We also observed that infant formula-fed infants ap-
pear to be most susceptible to differences in gut matur-
ity compared to MBM-fed infants. Stratification of the
groups based on birth weight or birth gestational age
and week of life [early <3 weeks vs. late >3 weeks] sug-
gested that microbial diversity for both IF-fed babies and
to a lesser extent PDHM-fed babies were significantly
influenced by gut maturity in late samples, whereas
MBM-fed babies exhibited no significant differences in
bacterial diversity (Additional file 2: Figure S2).
Succession of bacteria delayed by influence of gestational
age in IF-fed infants
As seen in Fig. 4a (and Additional file 1: Table S3), the
preterm infant gut is overwhelmingly comprised of spe-
cies from Bacillales and Lactobacillales until approxi-
mately 28–30 weeks of adjusted gestational age,
particularly in IF-fed infants, and most strikingly in IF
(and to a lesser extent PDHM)-fed ELBW infants that
retain high levels of Lactobacillales during the entire
period monitored. The infants fed MBM have a greater
initial diversity in their microbiome that is most strongly
influenced by the presence of a variety of phylotypes that
include lower levels of Bacillales and Lactobacillales, in
favor of Clostridia, and Enterobacteriales as early as
26 weeks of adjusted gestational age.
We compared the overall compositional differences of
the infant microbiome based on nutrition in samples ob-
tained after 3 weeks, with no antibiotic exposure within
7 days, and fit these to a linear mixed-effects models by
adjusted gestational age (see the “Methods” section;
Fig. 4b). Under both MBM and PDHM conditions, we
Fig. 3 Comparison of microbial diversity trajectories by diet and maturity. Linear mixed-effects (LME) model regressions of microbial diversity
(Shannon index) plotted by a postnatal day and b adjusted gestational age [gestational age + postnatal day at time of sample collection].
Adjusted gestational age reflects the overall maturity of the infant at the time of sample collection. Samples plotted included those >7 days post
antibiotic exposure for both panels [118 samples]. Lines represent linear mixed-effects regressions (and 95% confidence intervals) of Shannon diversity
over time for each infant (birth gestational age also included as a factor in panel a). The significance level for relating bacterial diversity over time
within each diet group is noted, as are the correlations and variance (panel c; based on “random effects”) of the model fit
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Fig. 4 Distinct succession of bacteria as a function of diet and maturity. a Mean class level microbiota relative abundance in VLBW and ELBW
infants by nutritional group and adjusted gestational age. b Linear mixed-effects (LME) modeled relative abundance and statistical analyses of the
four most common types of bacteria identified: Bacillales, Lactobacillales, Clostridiales, and Enterobacteriales reported by nutritional group
and adjusted gestational age [>3 weeks postnatal age, >7 days post antibiotics samples only plotted; 86 samples]. Individual infant trajectories (lines)
for each infant are plotted along with box and whiskers for LME-modeled relative abundance values. FDR-adjusted p values from the LME models
are noted
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observed a relatively ordered succession in bacterial taxa
with initial colonization dominated by Bacillales/Lactoba-
cillales giving way to Enterobacteriales then Clostridiales
and Bifidobacteriales. With IF feeding, a different trend
emerged where higher initial and persistent levels of Bacil-
liales/Lactobacillales seemed to delay colonization by
other taxa. The most striking trend was related to the
Enterobacteriales and was not observed at appreciable
levels until an adjusted gestational age of 34 weeks for IF-
fed babies while MBM-fed babies had high levels of Enter-
obacteriales from the 29th week. This also in turn ap-
peared to correlate with higher colonization levels of
Lactobacillales and to some extent less colonization of
Clostridiales. Support of the hypothesis that the delay in
appearance of Enterobacteriales is a consequence of spe-
cific Bacillales/Lactobacillales inhibiting colonization of
Enterobacteriales comes from negative correlations be-
tween particular genera within these groups (e.g., inverse
Spearman correlations between Bacillus and Citrobacter;
Additional file 3: Figure S3). Other differences between
the groups included a more rapid increase in Clostridiales
in the MBM and PDHM groups compared to the IF group
and lower overall relative abundance of Lactobacillales in
the MBM group compared to the IF and PDHM group.
Together, these observations suggest a dynamic interplay
between host and dietary selection of specific members of
the microbiome that is disrupted by feeding of infant
formula.
We next sought to investigate the influence, if any, of
nutrition on establishment of microbiome composition
by maturity of the infant at birth, as measured by gesta-
tional age at birth (Fig. 5a; samples > 3 weeks post birth).
Again, the infants who were fed MBM cluster together
regardless of birth weight (p = 0.049, R2 = 0.102) whereas
the infants fed infant formula cluster distinctly from one
another based on birth weight (p < 0.001, R2 = 0.568).
This finding may indicate that breast milk protects
against bowel immaturity associated with low birth
weight, whereas in contrast, the community composition
of infants fed IF can still be distinguished based on birth
weight. In Fig. 5b (and Additional file 1: Table S4), we
show the relative abundance of the 10 most common
classes of bacteria measured in our samples. Statistically
significant differences (based on the LME tests above) in
the MBM group were identified Clostridiales (p = 0.002).
In the IF group, statistically significant differences were
identified in Clostridiales (p = 0.028), Enterobacteriales,
and Lactobacillales (p < 0.01). In the IF-fed group, the
most significant differences were identified in the Clos-
tridiales, with VLBW infants having nearly ten times the
amount as ELBW infants.
Furthermore, we employed linear effect size feature se-
lection (LEfSe; [21]) to identify specific taxa that were
significantly associated with either MBM or IF diets
(Fig. 6). Enterobacteriales (specifically the Citrobacter)
and select Clostridiales (specifically Clostridium, Rumi-
nococcus, and Negativicoccus) were identified as the best
discriminators of MBM-fed infants. For IF-fed infants,
Lactobacillales (specifically Streptococcus), Bacillus, and
a distinct Clostridiales (Anaerococcus) were associated
with this group. The negative correlations in taxa rela-
tive abundance observed above (Additional file 3: Figure
S3) between Citrobacter and Bacillus likely reflect diet-
driven differences in these infant microbiomes. Together,
these analyses indicate that there are at least a handful
of signature taxa that characterize each nutritional regi-
men once a threshold of gut maturity is achieved.
Discussion
We know that initial colonization of the newborn gut
influences the development of intestinal host defense
[22, 23] and appropriate development may have a
profound effect on immune health during infancy and
throughout life [24]. This is in part because intestinal
immune health is immature at birth and develops in
conjunction with the initial colonization process. A
disruption in colonization and development of intestinal
host defense may account for the increase in allergy and
immune-mediated morbidity (i.e., autoimmune disease) in
developed countries over the last half century [25].
The host defense competency of the premature in-
testine is particularly immature and does not respond
to initial colonization in a manner similar to full
term, vaginally born, and breastfed infants [26]. For
example, we have shown that premature enterocytes
respond to an inflammatory stimulus with excessive
inflammation and can react to commensal bacteria
with higher levels of inflammation compared to ma-
ture human enterocytes [27, 28]. This suggests that
dysbiosis during the newborn period of preterm in-
fants may contribute to excessive intestinal inflamma-
tion leading to NEC.
We also know that breast milk as an exclusive source
of nutrition in full-term infants stimulates health-
promoting bacteria, known as “pioneer” bacteria that
directly influence the development of host defense [29].
We also know that expressed breast milk from mothers
delivering prematurely protects the infant from NEC
[17, 18]. Although breast milk contains many passive
protective factors (IgA, oligosaccharides, lactoferrin, etc.)
that may contribute to the protection against inflamma-
tion and NEC, it may also provide an active role in the
stimulation of health-promoting bacteria that provide
protection against NEC. Several studies have suggested
that probiotics given to preterm infants may also protect
against NEC [30], and a recent report suggests that a
combination of probiotics and breast milk may be most
protective [31]. Since no studies have been conducted to
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determine the influence of breast milk on intestinal
colonization in preterm infants, we studied the compos-
ition of intestinal microbiota in preterm infants using
three standard feeding regimes: (1) exclusive ingestion of
expressed MBM; (2) ingestion of PDHM followed by IF;
and (3) exclusive ingestion of preterm IF. We hypothe-
sized that ingestion of expressed MBM by preterm in-
fants may also promote a healthy gut by the stimulation
of a unique, protective intestinal microbiome and that
this microbiome may provide protection against the ex-
cessive intestinal inflammation of prematurity by stimu-
lating “pioneer” bacteria.
We found that the intestinal microbiome composition
of preterm infants differed over time depending on feed-
ing with MBM, PDHM, or IF and that these differences
are also influenced by gestational age at birth and
Fig. 5 Impact of diet on microbiome composition by maturity. a PCA scatterplots of microbiota composition in late (>3 week) samples only by
nutritional group. b Relative abundance of the 10 most common classes of bacteria measured. # indicate significance based on LME modeling as
a function of adjusted gestational age (FDR-adjusted p > 0.05; Additional file 1: Table S4)
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postnatal age at the time of observation. The micro-
biomes of infants who were fed MBM clustered separ-
ately from the infants who were fed IF after the first
3 weeks following birth. The intestinal microbiome of
infants fed IF was most influenced by differences in ges-
tational age, while the intestinal microbiome of infants
fed MBM was more resilient to the influence of gesta-
tional age, following a similar trajectory regardless of the
gestational age at birth or postnatal age at the time of
measurement. Feeding with PDHM had a varied influ-
ence on the intestinal microbiome based on gestational
age of the infant. In infants born prior to 28 weeks,
PDHM did not bring the infants to an MBM-like intes-
tinal microbiome but did influence colonization by spe-
cific taxa. Infants who were greater than 28 weeks and
fed PDHM did develop a microbiome that more closely
resembled that of the MBM-fed infants. These observa-
tions differ from a previous report [9] suggesting that
diet and other environmental factors (i.e., the delivery
mode or perinatal antibiotics use) only delayed the final
composition of intestinal microbiota rather than having
a meaningful influence on the assembly of the micro-
biome during early infancy. In this study, by addressing
the influence of diet in preterm infants, we showed pro-
found effects on the composition and diversity of the
colonizing intestinal population.
When the microbial structure was examined based on
diet, postnatal age at the time of sample collection, and
gestational age, 40% of the variance was explained by
these three factors. This suggests that feeding with
MBM may mask some of the influence of birth weight
and in turn, gestational age at birth. Maturation of the
gut (i.e., gestational age at birth) appears to drive the tra-
jectory of colonization of the intestinal microbiome in a
nutritionally dependent manner, but only after the early
colonization period that appears to occur during the first
3 weeks of life. This may represent an (noisy) establish-
ment period for the microbiome where bona fide com-
mensals can get a foothold before host and dietary
factors select and enrich for their continued presence.
Together, MBM-fed infant samples appeared to be more
similar and robust in that they were less influenced by
birth weight or gestational age, a proxy for gut maturity,
while the converse is true for IF-fed infants where com-
position is greatly influenced by birth weight and gesta-
tional age.
When comparing the difference by linear mixed-
effects modeling of diversity among the three groups of
preterm infants fed by different means, the findings re-
ported here suggest that preterm infants fed IF start with
a less diverse, more uniform intestinal microbiome that
is overwhelmingly populated by just a few types of bac-
teria, while the infants fed MBM have a more diverse
microbiome earlier in life and as a result, a more gradual
trajectory towards greater diversity over time. The pres-
ence of more bacterial species early in life, as seen in the
MBM-fed infants, and the slower trajectory towards in-
creased acquisition of diversity within the intestinal
microbiome may be preferable for the preterm infant
not only because a greater diversity early in life is likely
to be health promoting but also because a rapid increase
in microbial load may be associated with an overwhelm-
ing inflammatory response during infancy [32].
There are several factors unique to breast milk when
compared to infant formula that likely contributes to the
increased diversity observed in this study of preterm in-
fants who are routinely administered antibiotics follow-
ing birth. First, oligosaccharides present in breast milk
provide an energy source to the intestinal microbiome,
facilitating the growth of bacterial species, many of
which are characterized as beneficial (i.e., commensal
bacteria) to the infant gut [33, 34]. Second, breast milk
Fig. 6 Microbes that are discriminative of infant diet. Histogram of linear discriminant analyses (LDA) effect size (LEfSe) method identified taxa
that are most associated with microbiomes of MBM- and IF-fed infants. No characteristic taxa were observed within PDHM-fed infants, suggesting
a more heterogeneous response that largely overlaps with either IF or MBM groups
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contains multiple bacterial species, now referred to as
the milk microbiomes [35] that actively colonize the gut.
And third, breast milk contains other bioactive factors
such as secretory IgA, which has been shown to alter
colonization of the infant gut, protecting it against
pathogenic bacteria [36, 37]. None of these factors are
present in IF, presumably contributing to the lower di-
versity index initially observed among IF-fed preterm in-
fants, as well as the more rapid acquisition of microbes,
the majority being acquired from the hospital environ-
ment. In sum, breast milk not only modifies the environ-
ment of the infant gut to protect against pathogenic
bacteria, it also facilitates colonization with commensal
bacteria that promote short- and long-term immune
health of the host.
Infants who receive MBM and have a greater num-
ber and diversity of bacterial species present in their
intestinal microbiome do not appear to have an im-
mune system that is overwhelmed by the acquisition
of the bacteria present in their microbiome, which
are being introduced from the milk or the environ-
ment. A possible explanation is that during infancy,
the immune system is weakened for the purpose of
acquiring intestinal bacteria [32]. The resistance to
infections that is known to be suppressed during
infancy may be designed to prevent overwhelming in-
flammation associated with the process of bacterial
colonization following birth. Exposure to innate
defense proteins present in MBM is another factor
that is likely to mitigate intestinal inflammation and
immune system activation in the setting of a more di-
verse intestinal microbiome during infancy [38]. For
example, human milk is known to have host defense
properties as a result of proteins such as lactoferrin,
lysozyme, secretory IgA, IgG, secretory component,
and complement C3. While these have been shown to
be present at lower concentrations in milk expressed
from mothers following preterm birth, they are not
significantly different from that of the milk expressed
following a full-term gestation [39]. These findings
help explain why MBM-fed preterm infants, who we
show here to have a more diverse intestinal micro-
biome when compared to their IF-fed counterpart, do
not have an overwhelming immune response to ac-
quisition of the microbiome following birth.
Finally, we investigated the impact of nutrition on the
microbiome composition by maturity at birth. Our data
provide further evidence suggesting that feeding with
MBM masks the influence of varied degrees of immatur-
ity of the gut at birth. In contrast, feeding IF does not
appear to have this protective influence on the preterm
infant intestinal microbiome. This finding may further
explain the role that MBM plays in protecting the pre-
mature gut from NEC.
Donated milk from milk banks, which was fed to the
infants in this study, undergoes complex handling fol-
lowing collection and prior to delivery. This typically in-
cludes two freeze thaw cycles, as well as the Holder
method of pasteurization. These processes have been
shown to alter the macro- and micronutrient content, as
well as the bioactivity of the milk. For example, PDHM
has been shown to be lower in sIgA and lactoferrin than
unpasteurized milk [40, 41]. More research on the influ-
ence of milk storage and pasteurization conditions rela-
tive to the specifics of the milk microbiome and
presence or absence of bioactive factors, including
HMOs and other glycans, is needed to guide the optimal
clinical utility of this milk.
Greater study of PDHM is needed in light of our lim-
ited understanding of the influence of storage and
pasteurization conditions on the bioactive content of
this milk, and importantly, whether this influences the
health of the preterm infant. Our study is one of the first
to explore differences in the assembly of the preterm in-
fant intestinal microbiome following supplementation
with PDHM and provides important observations re-
garding the influence of diet on early microbial health.
Future work exploring markers of interaction between
the microbiome and the host (i.e., measures of host im-
mune response to the microbiome and metabolism) will
be based on this study. Overall, we did not find supple-
mentation with PDHM to have a striking influence on
the microbiome after the infants were transitioned onto
IF (this transitioned occurred by 4–5 weeks of age). We
did observe some similarities among VLBW infants fed
PDHM with their MBM counterparts [e.g., slower in-
creases in bacterial diversity], but later samples resem-
bled more often either those of IF group or a hybrid
composition intermediate between the MBM and IF
groups. While the infants fed PDHM did not clearly
cluster together with either the “MBM microbiome” or
the “IF microbiome,” there were some interesting differ-
ences based on birth weight and specific taxa present in
the microbiome. For example, when accounting for ges-
tational age, we observed an overall similar colonization
levels for two of the four most abundant bacterial orders
in infants fed PDHM [i.e., better colonization of Entero-
bacteriales and Clostridiales like MBM-fed infants] but
still had considerably higher levels of Lactobacillales
similar to IF-fed infants. This is an important finding as
it suggests that for these infants, exposure to PDHM
prior to IF has an influence on some members of the
microbiome that mirror that of the MBM-fed infants.
More research is needed, but these findings suggest that
there may be some influence on the microbiome associ-
ated with early exposure to PDHM when compared to
IF, perhaps as a result of specific glycans that survive the
milk storage and pasteurization processes.
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In this study, we analyzed specific bacteria in each
feeding group. Clearly, these bacterial taxa differed
between the MBM-fed and IF-fed groups. As stated,
the PDHM group had an intermediate response. We
then sought to determine the persistent effect of diet
on microbiome composition. Again, the MBM group
clustered together regardless of birth weight while the
IF group was strongly influenced by birth weight.
These preliminary observations indicate that mode of
feeding, particularly MBM, had a specific influence on
the nature of microbiota colonization in the preterm
infant. Further analysis will be necessary to identify
specific species and strain differences before more
studies can be done.
The studies reported here suggest that expressed
MBM has a significant impact on initial colonization of
the preterm infant’s intestine and differs from other
forms of neonatal nutrition. Moreover, this work sug-
gests that the association of nutrition and microbiota
may be key for maintaining intestinal health and in turn
the prevention of NEC in this patient population. How-
ever, to demonstrate a direct association, further ana-
lyses are needed that employ a combination of isolates
of specific species and in vitro techniques that we have
pioneered (e.g., a fetal human small intestinal cell line
(H4 cells) [42], fetal intestinal organ cultures [43], fetal
intestinal xenografts [44], and organoids [45]), which
could help to determine if these species specific breast
milk-stimulated bacteria inhibit the intestinal inflamma-
tory response. These observations should provide pos-
sible new probiotic protocols in combination with
expressed breast milk that can be used in clinical trials
and then possibly incorporated into routine care of the
preterm infant.
Conclusions
The preterm infant intestinal microbiome is influenced
by postnatal time, gestational age, birth weight, and nu-
tritional exposures. Feeding with MBM appears to mask
the influence of birth weight, suggesting a protective ef-
fect against gut immaturity of the preterm infant early in
life. Further study is needed regarding the influence of
feeding with PDHM or IF on acquisition of the intestinal
microbiome, which based on our results appears to
occur in a gestational age dependent manner. These
findings not only suggest a microbial mechanism under-
pinning the body of evidence showing that breast milk
promotes intestinal health of the preterm infant, but also
the dynamic interplay of host and dietary factors that fa-
cilitate the colonization of and enrichment for specific
microbes during establishment of the preterm infant in-
testinal microbiota.
Methods
Study cohort and design
The infants included in this study were an otherwise
healthy population of preterm infants born prior to
32 weeks of gestation. The cohort of infants was care-
fully assembled such that there were three groups of 10
infants that differed only on their nutritional exposures
of MBM, PDHM, and IF. Inclusion in one of the three
groups required that the infant be fed 100% MBM, 100%
IF, or the hospital’s PDHM protocol. Within the three
groups of infants, other than nutritional history, there
were no statistically significant differences in gestational
age, birth weight, or mode of delivery. Neonatal morbid-
ities such as incidence of patent ductus arteriosus
(PDA), sepsis, or necrotizing enterocolitis (NEC) were
also used as exclusion criteria for selection of this cohort
Table 1 Descriptive characteristics of preterm infants (n = 30)
MBM (n = 10) PDHM (n = 10) IF (n = 10) p
Mean (SD)
Birth weight (g) 1044 (257.6) 1070 (421.9) 1175 (348.3) 0.660
Gestational age (weeks) 28.4 (1.5) 28.4 (2.1) 28.2 (2.5) 0.971
Days to full feeds 15.10 (4.2) 16.4 (8.1) 14.45 (6.8) 0.794
First day of enteral feeding 3.8 (1.8) 5.4 (3.8) 3.9 (2.0) 0.359
N (%)
Sepsis 0 (0) 2 (20) 2 (20) 0.332
NEC 0.338
Medical 0 (0) 1 (10) 0 (0)
Surgical 0 (0) 0 (0) 0 (0)
Perf 0 (0) 0 (0) 0 (0)
PDA 1 (10) 1 (10) 3 (30) 0.778
Birth mode
Cesarean section 9 (90) 9 (90) 9 (90) 0.809
MBM maternal breast milk, PDHM pasteurized donor human milk, IF infant formula
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and thus were also not significantly different between
the study groups. The considerations given to study de-
sign and cohort assembly in this research resulted in our
ability to evaluate the influence of diet on the preterm
infant intestinal microbiome over time. These results are
shown in Table 1. The study design is shown in Add-
itional file 4: Figure S1 along with accompanying sample
metadata in Additional file 1: Table S1.
Clinical methods
All study procedures followed a protocol that was ap-
proved by the Partner’s Human Research Committee
(IRB) for Brigham and Women’s Hospital and Massa-
chusetts General Hospital (Protocol #2012-P-002453).
All infants were born at Brigham and Women’s Hospital
in Boston, MA, and cared for in a single-center
Newborn Intensive Care Unit (NICU). Fecal samples
were collected from preterm infants born prior to
32 weeks of gestation from birth until discharge or
60 days of life, whichever came first. Briefly, diapers with
fecal samples were collected daily by the bedside nurse,
placed in a specimen bag, and stored at 4 °C for no more
than 24 h. Samples were processed daily, which involved
extraction of fecal material from infant diapers using
sterile procedures, and immediately frozen at −80 °C de-
grees until analyzed. The nutritional intake of the infants
was prospectively monitored but never influenced by
this observational study. When infants who were fed
predominantly 100% MBM, 100% IF, or the standard
hospital’s PDHM protocol were identified, their fecal
samples were selected for analysis in this study. Follow-
ing the hospital protocol, infants who were fed PDHM
transitioned to IF after they achieved full enteral feeding
(defined as >140 cc/kg/day). In addition, infants on this
protocol weighing less than 1000 g at birth were re-
quired to exceed 1000 g in weight prior to transitioning
from PDHM to IF.
Adjusted gestational age is calculated by adding post-
natal day to gestational age at birth. For example, an in-
fant born at 24 weeks who is now 16 days old has an
adjusted gestational age of 26 weeks and 2 days, and an
infant who is born at 26 weeks who is now 2 days old
has an adjusted gestational age of 26 weeks and 2 days.
Adjusted gestational age, sometimes called corrected age
or post conceptual age, is often used to give a more ac-
curate assessment of the overall maturity of the preterm
infant and to compare across infants regardless of gesta-
tional age at birth.
DNA extraction and sequencing
Samples were stored at −80 °C until the time of analysis.
At the time of analysis, DNA was isolated from approxi-
mately 200 mg of fecal material using a commercially
available kit that included a bead-beating step (MO-Bio,
Carlsbad, CA). Isolated DNA from these samples (n =
221) was then arrayed into 96-well plates, quality deter-
mined (agarose gel), quantity normalized (by nanodrop
and/or PicoGreen), and stored at −20 °C until further
processing. The V4–V5 region of the 16S rRNA gene
was amplified using 515 F (5′- CCTACGGGAGGCAG
CAG -3′) and 806R (5′- CCGTCAATTCMTTTRAGT
-3′) with unique Golay-barcoded primers (on the reverse
primer) and sequencing adapters as described in the Earth
Microbiome Project (http://www.earthmicrobiome.org/;
[46]). To construct sequencing libraries, amplicons were
purified and pooled to equimolar concentrations
(PicoGreen), then sequenced using an Illumina MiSeq se-
quencer (paired-end 250-bp reads with v2 500 cycles kit).
The raw fastq files from sequencing were processed
with the QIIME software package (v1.7.0) [47]. Briefly,
sequences were truncated at the first low-quality base
and quality filtered to remove reads with an average
quality score below 25, reads shorter than 225 bp, reads
with more than 1 ambiguous base, primer mismatches,
and erroneous barcodes that could not be corrected
using the Golay barcodes. Chimeric reads were removed
using ChimeraSlayer [48]. The resulting dataset of qual-
ity filtered, non-chimeric of 16S rRNA gene sequences
were down-sampled randomly to a maximum of 25,000
reads per sample for ease of analysis, and de novo oper-
ational taxonomic unit (OTU) picking was performed
with the uclust option in QIIME [49]. Representative
OTU sequences were aligned using the PyNAST algo-
rithm with a minimum percent identity of 80% [50].
Taxonomic assignment of representative OTUs was
completed using the Ribosomal Database Project (RDP)
classifier [51] (greengenes 12_10). OTUs that were not
identified in at least two independent samples with at
least ten total reads and samples with less than 2145
reads were filtered from the dataset. 2501 OTUs were
identified in the final dataset, which included 199 sam-
ples with a median of 23,309 per sample and a total of
4.1 million total reads.
For estimates of alpha diversity (within sample) and
taxa relative abundance, samples were rarefied to
2145 sequences to allow for inclusion of all samples,
while beta-diversity (between sample) metrics were
rarefied to 6945 sequences (191 total samples) to
allow for greater discrimination of microbiome com-
position. Alpha diversity metrics—i.e., Shannon index
(H′)—were computed within QIIME using default pa-
rameters and plotted using phyloseq [52]. Principle
component analyses (PCA) were completed using
Bray-Curtis dissimilarity distance matrices [53] to fa-
cilitate comparisons of presence/absence patterns be-
tween samples; Bray-Curtis matrices best explained
the variance of the samples (highest % variation ex-
plained by the top three PCA coordinates), though
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weighted and unweighted UniFrac metrics [51, 54]
(among others) were also examined.
Statistical analyses
Infant microbiome characteristics were assessed for their
significance using the R software package (version 3.2.4;
http://www.r-project.org/). Normally distributed vari-
ables (i.e., Shannon index) were statistically tested by an
unpaired t test for two independent groups or a one-way
analysis of variance (ANOVA) for multiple independent
groups. Changes in diversity over time were evaluated by
linear mixed-effects modeling in R using the nlme::lme
package (v3.1-128; [55]). The infant was included as a
random effect for both the intercept and the slope of the
estimated fit for analyses of postnatal day and adjusted
gestational age, while birth gestational age was also in-
cluded in models based on postnatal days [nlme formu-
las − adjusted gestational age, ~1 + AdjSampleGestAge |
InfantID; postnatal day, ~1 + SamplePNDay | InfantID +
1 | BirthGestAge]. Non-normally distributed variables
(e.g., UniFrac, Bray-Curtis PCA) were statistically tested
using PERMANOVA test followed by a Mann-Whitney
U test for two independent groups or a Kruskal-Wallis
test for multiple independent groups. Similar to diversity
measures, significance of taxa relative abundance was
determined using linear mixed-effects modeling as a
function of adjusted gestational age using Calypso
(http://bioinfo.qimr.edu.au/calypso/) [LME formula −
relative taxa abundance = InfantID + AdjSampleGestAge
+ StudyGroup]. We sought to minimize the prevalence of
zeros by summarizing taxa differences at the class level
(<10% of values) and minimize the influence of the
remaining zeros by transforming the datasets using arcsin
square root methods (similar to [9, 56]) prior to building
the LME models of relative taxa abundance. There are re-
cent methods that explicitly address zero-inflated datasets
(i.e., ZIBR [57]); however, the requirements for samples at
the same timepoints in every condition were incompatible
with our cohort even after imputation of missing samples
[<30% of samples able to be used over a narrow range in
adjusted gestational age (32–34 weeks)]. Perhaps, with a
larger cohort of infants and relaxed tolerance of such
datasets in future versions of the software, these limita-
tions can be overcome.
For all analyses, the threshold significance level was set
at 0.05. Corrections based on multiple testing were per-
formed by the Benjamini-Hochberg false discovery rate
procedure [58]. Linear effect size (LEfSe) analysis was per-
formed using the default parameters to identify features
that discriminated our dietary groups of interest [21].
Data including 16S rRNA gene data and metadata has
been made available via the SRA database. The SRA ac-
cession number for publications referencing this dataset
is SRP079978.
Additional files
Additional file 1: Table S1. Per sample key metadata parameters.
Table S2. Per sample Shannon diversity indices. Table S3. Mean taxa
relative abundance values by postnatal time and birth weight class.
Table S4. Mean taxa relative abundance values by birth weight class
alone. (XLS 106 kb)
Additional file 2: Figure S2. Bacterial diversity within nutrition groups
is selectively sensitive to gestational age and birth weight. Box and
whisker plots of Shannon diversity indices for each of the study groups
by postnatal age (<3 weeks (early) vs. >3 weeks (late)) summarized by (A)
birth gestational groups [<26 weeks, 27–29 weeks and 30–32 weeks] and
(B) birth weight [ELBW and VLBW]. Samples plotted included those
>7 days post antibiotic exposure for both panels [118 samples]. LME
models of significance as a function of diet and gestational age (p <
0.001) or postnatal day (p < 0.05) are noted in Fig. 3. (PDF 2200 kb)
Additional file 3: Figure S3. Genera co-occurrence analyses. Spearman
rank co-efficient analyses of relative abundance of a given genera in all of
the 199 samples as a group. Strong negative correlations between select
Enterobacteriales [Enterobacter, Trabusiella and Citrobacter] and Bacillales
[Staphylococcus and Bacillus] are shown. (PDF 2540 kb)
Additional file 4: Figure S1. Study design for longitudinal
examination of nutritional exposures on preterm infant microbiome.
Infants grouped by one of three feeding groups: mothers breast milk
(MBM), pasteurized human donor milk (PDMH), and infant formula (IF).
Samples analyzed on days indicated with an “X”. Feeding code for each
day as follows: gray = NPO, red = MBM, blue = PDHM, yellow = IF. Days
when a combination of feeding types were fed indicated in purple
(MBM/PDHM), orange (MBM/IF), green (PDHM/IF), or brown (MBM, PDHM, IF).
Birth delivery mode indicated by cesarean section (CS) or vaginal (V).
Maternal antibiotics during labor and birth indicated by yes (Y). (PDF 2210 kb)
Acknowledgements
The authors wish to acknowledge the clinical staff, as well as patients and
families, of the Newborn Intensive Care Unit at Brigham and Women’s
Hospital. The authors also wish to thank Ms. Suzzette McCarran and Ms. Irene
Miller for their assistance with this manuscript.
Funding
This study was supported by grants from the National Institutes of Health,
Bethesda, MD (R01 HD059126; R01 HD012437, P01 DK033506, P30 DK040561
to WAW) (K23 NR 011320to KEG).
Availability of data and materials
The dataset supporting the conclusions of this article will be available in the
Sequence Read Archive (SRA) prior to publication of this manuscript. A
unique persistent identifier and hyperlink to the dataset in http:// format will
be made available as soon as possible.
Authors’ contributions
KEG participated in the conception of the study, led the design and cohort
selection, participated in the analysis and interpretation of the data, and
helped write the manuscript. BSS carried out the molecular studies, led the
analytical approach to the data, and helped write the manuscript. PH and GS
assisted with the clinical methods and sample preparation for the analysis.
RS and FA directed the molecular sequencing. WAW participated in the
conception of the study, oversaw the analysis and interpretation of the data,
and helped write the manuscript. All authors read and approved the final
draft of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Gregory et al. Microbiome  (2016) 4:68 Page 13 of 15
Ethics approval and consent to participate
This study was approved by the Partner’s Human Research Committee (IRB)
for Brigham and Women’s Hospital and Massachusetts General Hospital
(Protocol #2012-P-002453).
Author details
1Department of Pediatric Newborn Medicine, Brigham and Women’s
Hospital, 75 Francis Street, Boston, MA 02115, USA. 2Alkek Center for
Metagenomics and Microbiome Research, Department of Molecular Virology
and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
3Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA.
4Cooper Medical School, Camden, NJ, USA. 5Department of Molecular
Biology, Massachusetts General Hospital, Department of Genetics, Harvard
Medical School, Boston, MA, USA. 6Department of Molecular Biology,
Massachusetts General Hospital, Department of Pathology, Harvard Medical
School, Boston, MA, USA. 7Department of Pediatrics, Mucosal Immunology
and Biology Research Center, Massachusetts General Hospital for Children,
Harvard Medical School, Boston, MA, USA.
Received: 12 April 2016 Accepted: 29 November 2016
References
1. Weng M, Walker WA. The role of gut microbiota in programming the
immune phenotype. J Dev Orig Health Dis. 2013;4:203–14.
2. Palmer C, Bik EM, DiGiulio, Relman DA, Brown PO. Development of the
human infant intestinal microbiota. PLoS Biol. 2007;5(7):1556–73.
3. Houghteling P, Walker WA. Why is initial bacterial colonization of the
intestine important to the infant’s and child’s health? J Pediatr Gastroenterol
Nutr. 2015;60:294–307.
4. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer
N, et al. Delivery mode shapes the acquisition and structure of the initial
microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U
S A. 2010;107(26):11971–5.
5. Zeissig S, Blumberg RS. Life at the beginning: perturbation of the
microbiota by antibiotics in early life and its role in health and disease. Nat
Immunol. 2014;15(4):307–10.
6. Brooks B, Firek BA, Miller CS, Sharon I, Thomas BC, Baker R, et al. Microbes in
the neonatal intensive care unit resemble those found in the gut of
premature infants. Microbiome. 2014;2(1):1.
7. Ardeshir A, Narayan NR, Méndez-Lagares G, Lu D, Rauch M, Huang Y, et
al. Breast-fed and bottle-fed infant rhesus macaques develop distinct
gut microbiotas and immune systems. Sci Transl Med. 2014;6(252):
252ra120.
8. Jost T, Lacroix C, Braegger CP, Chassard C. New insights in gut microbiota
establishment in healthy breast fed neonates. PLoS One. 2012;7:e44595.
9. LaRosa P, Warner B, Zhou Y, Weinstock GM, Sodergren E, Hall-Moore CM, et
al. Patterned progression of bacterial populations in the premature infant
gut. Proc Natl Acad Sci U S A. 2014;111(34):12522–7.
10. Schwartz S, Friedberg I, Ivanov IV, Davidson LA, Goldsby JS, Dahl DB, et al. A
metagenomic study of diet-dependent interaction between gut microbiota
and host in infants reveals differences in immune response. Genome Biol.
2012;13(4):r32.
11. Gk S, Ostbye T, Skjaerven R. Association of preterm birth with long-term
survival, reproduction, and next-generation preterm birth. JAMA. 2008;
299(12):1429–36.
12. Eichenwald EC, Stark AR. Management and outcomes of very low birth
weight. N Engl J Med. 2008;358(16):1700–11.
13. Patel RM, Kandefer S, Walsh MC, Bell EF, Carlo WA, Laptook AR, et al. Causes
and timing of death in extremely premature infants from 2000 through
2011. N Engl J Med. 2015;372(4):331–40.
14. Zhou Y, Shan G, Sodergren E, Weinstock G, Walker WA, Gregory KE.
Longitudinal analysis of preterm intestinal microbiome prior to necrotizing
enterocolitis: a case-control study. PLoS One. 2015;10(3):e0118632.
15. Agostoni C, Braegger C, Decsi T, Kolacek S, Koletzko B, Michaelsen KF, et al.
Breast-feeding: a commentary by the ESPGHAN Committee on Nutrition.
J Pediatr Gastroenterol Nutr. 2009;49:112–25.
16. Rautava S, Walker WA. Academy of Breastfeeding Medicine founder’s lecture
2008: breastfeeding—an extrauterine link between mother and child.
Breastfeed Med. 2009;4(1):3–10.
17. McGuire W, Anthony MY. Donor human milk versus formula for preventing
necrotizing enterocolitis in preterm infants: systematic review. Arch Dis
Child Fetal Neonatal Ed. 2003;88:F11–4.
18. Lucas A, Cole TJ. Breast milk and neonatal necrotizing enterocolitis. Lancet.
1990;336:1519–23.
19. Vohr BR, Poindexter BB, Dusick AM, McKinley LT, Wright LL, Langer JC, et al.
Beneficial effects of breast milk in the neonatal intensive care unit on the
developmental outcome of extremely low birth weight infants at
18 months of age. Pediatrics. 2006;118(1):e115–23.
20. DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A,
et al. Temporal and spatial variation of the human microbiota during
pregnancy. Proc Natl Acad Sci U S A. 2015;112(35):11060–5.
21. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS,
Huttenhower C. Metagenomic biomarker discovery and explanation.
Genome Biol. 2011;12(6):R60.
22. Kaplan JL, Shi H, Walker WA. The role of microbes in developmental
immunologic programming: convergence of the barker and hygiene
hypotheses. Pediatr Res. 2011;9(6):465–72.
23. Artis D. Epithelial-cell recognition of commensal bacteria and
maintenance of immune homeostasis in the gut. Nat Rev Immunol.
2008;8(6):411–20.
24. Round JL, Maxmanian SK. The gut microbiota shapes intestinal responses
during health and disease. Nat Rev Imunol. 2009;9(5):313–23.
25. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W,
et al. Mechanism of disease: the hygiene hypothesis revisited. Nat Clin Pract
Gastroenterol Hepatol. 2006;3(5):275–84.
26. Martin CR, Walker WA. Innate and mucosal immunity in the developing GI
tract: relationship to early and later disease. In: Gleason, Devaskar, editors.
Avery’s diseases of the newborn. 9th ed. Philadelphia: Elsevier/Saunders;
2011. p. 994–1006.
27. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ.
Developmentally regulated IkappaB expression in intestinal epithelium and
susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci U S A.
2004;101(19):7404–8.
28. Nanthakumar N, Meng D, Goldstein AM, Zhu W, Lu K, Uauy R, Llano A,
Claud EC, Walker WA. The mechanism of excessive intestinal inflammation
in necrotizing enterocolitis: an immature innate immune response. Plos
One. 2011;6(3):e17776.
29. Groer MW, Gregory KE, Louis-Jacques A, Thibeau S, Walker WA. The very low
birth weight infant microbiome and childhood health. Birth Defects Res C
Embryo Today. 2015;105(4):252–64.
30. Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in
intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2010;7(9):503–14.
31. Repa A, Thanhaeuser M, Endress D, Weber M, Kreissl A, Binder C, Berger A,
Haiden N. Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum)
prevent NEC in VLBW infants fed breast milk but not formula. Pediatr Res.
2015;77(2):381–8.
32. Shokrollah E, Ertelt JE, Kinder JM, Jiang TT, Zhang X, Xin L, et al. Babies’
weak immune systems let good bacteria in. Nature. 2013;504(7478):158–62.
33. Underwood MA, Gaerlan S, De Leoz ML, Dimapasoc L, Kalenetra KM, Lemay DG,
et al. Human milk oligosaccharides in premature infants: absorption, excretion,
and influence on the intestinal microbiota. Pediatric Res. 2015;78(6):670–7.
34. Musilova S, Rada V, Vlkova E, Bunesova V. Beneficial effects of human milk
oligosaccharides on gut microbiota. Benef Microbes. 2014;5(3):273–83.
35. Hunt KM, Foster JA, Forney LJ, Shutte UM, Beck DL, Abdo Z, et al.
Characterization of the diversity and temporal stability of bacterial
communities in human milk. PLoS One. 2011;6(6):e21313.
36. Bridgman SL, Konya T, Azad MB, Sears MR, Becker AB, Turvey SE, et al. Infant
gut immunity: a preliminary study of IgA associations with breastfeeding.
J Dev Orig Health Dis. 2016;7(1):68–72.
37. Gregory KE, Walker WA. Immunologic factors in human milk and disease
prevention in the preterm infant. Curr Pediatr Rep. 2013;1:222–8.
38. Hettinga K, van Valenberg H, de Vries S, Boeren S, van Hooijdonk T, van
Arendonk J. The host defense proteome of human and bovine milk. PLoS
One. 2011;6(4):e19433.
39. Broadhurst M, Beddis K, Black J, Henderson H, Nair A, Wheeler T. Effect of
gestation length on the levels of five innate defence proteins in human
milk. Early Hum Dev. 2015;91(1):7–11.
40. Chang JC, Chen CH, Fang LJ, Tsai CR, Chang YC, Wang TM. Influence of
prolonged storage process, pasteurization, and heat treatment on
biologically-active human milk proteins. Pediatr Neonatol. 2013;54(6):360–6.
Gregory et al. Microbiome  (2016) 4:68 Page 14 of 15
41. Akinbi H, Meinzen-Derr J, Auer C, Ma Y, Pullum D, Kusano R. Alterations in
the host defense properties of human milk following prolonged storage or
pasteurization. J Pediatr Gastroenterol Nutr. 2010;51(3):347–52.
42. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in
the developing human intestine: a possible pathophysiologic contribution
to necrotizing enterocolitis. Proc Natl Acad Sci U S A. 2000;97(11):6043–8.
43. Meng D, Zhu W, Shi HN, Lu L, Wijendran V, Xu W, Walker WA. Toll-like
receptor-4 in human and mouse colonic epithelium is developmentally
regulated: a possible role in necrotizing enterocolitis. Pediatr Res. 2015;
77(3):416–24.
44. Nanthakumar NN, Klopcic C, Fernandez I, Walker WA. Normal and
glucocorticoid induced development of the human small intestinal
xenograft. Am J Physiol Regul Integr Comp Physiol. 2003;285(1):R162–70.
45. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, et al. Long-
term expansion of epithelial organoids from human colon, adenoma,
adenocarcinoma, and Barrett’s epithelium. Gastroenterology. 2011;141(5):1762–72.
46. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al.
Ultra-high-throughput microbial community analysis on the Illumina HiSeq
and MiSeq platforms. ISME J. 2012;6(8):1621–4.
47. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello
EK, et al. QIIME allows analysis of high-throughput community sequencing
data. Nat Methods. 2010;7(5):335–6.
48. Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, et al.
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-
pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494–504.
49. Edgar RC. Search and clustering orders of magnitude faster than BLAST.
Bioinformatics. 2010;26(19):2460–1.
50. Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R.
PyNAST: a flexible tool for aligning sequences to a template alignment.
Bioinformatics. 2010;26(2):266–7.
51. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid
assignment of rRNA sequences into the new bacterial taxonomy. Appl
Environ Microbiol. 2007;73(16):5261–7.
52. McMurdie PJ, Holmes S. phyloseq: an R Package for reproducible interactive
analysis and graphics of microbiome census data. PLoS One. 2013;8(4):
e61217.
53. Bray JR, Curtis JT. An ordination of the upland forest communities of
Southern Wisconsin. Ecol Monogr. 1957;27(4):325–49.
54. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing
microbial communities. Appl Environ Microbiol. 2005;71(12):8228–35.
55. Pinheiro J, Bates D, DebRoy S, Sarkar D and R Core Team (2016). nlme: linear
and nonlinear mixed effects models. R package version 3.1-128, http://
CRAN.R-project.org/package=nlme. Accessed 3 Oct 2016.
56. Kostic AD, Gevers D, Siljander H, Vatanen T, Hyötyläinen T, Hämäläinen
A-M, Peet A, et al. The dynamics of the human infant gut min
development and in progression towards type 1 diabetes. Cell Host
Microbe. 2015;17(2):260–73.
57. Chen EZ, Li H. A two-part mixed-effects model for analyzing longitudinal
microbiome compositional data. Bioinformatics. 2016;32(17):2611–7.
58. Benjamini YH, Yosef H. Controlling the false discovery rate: a practical and
powerful approach to multiple testing. J Roy Stat Soc B Met. 1995;57(1):
289–300.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Gregory et al. Microbiome  (2016) 4:68 Page 15 of 15
